When I deployed to Sierra Leone during the 2014-2016 West Africa Ebola epidemic, I understood the risks. Every physician, nurse, epidemiologist, laboratorian, and aid worker who...
Deep Science Ventures (DSV) and Medicine Discovery Catapult (MDC) agreed to collaborate to address challenges in delivering medicines into the brain. One of medicine’s greatest challenges...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Even though RevMed’s experimental pancreatic cancer...
The American Diabetes Association’s annual congress will feature a superstar lineup, including weight loss giants Eli Lilly and Novo Nordisk. But several scrappy biotechs will also...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. The American Diabetes Association’s annual conference starts today....
Fulcrum lays off 85% of staff after dropping asset, leaving 9 employees
The FDA must provide consistent and predictable regulatory frameworks if the U.S. is to maintain its leadership in gene therapy, one of the most consequential therapeutic...
Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data
News round-up for 1 June – 5 June by Bruno Quinney, Content Team at DDW. This week, a cancer drug has demonstrated it could reduce tumours by as...
The FDA hasn’t been transparent and open enough with how it has implemented the Commissioner’s National Priority Voucher program, patient, industry and trade groups said Thursday.